DFNA5 overexpression can cause significant enhancement of the secretion levels of many inflammatory factors, including interleukin MIP1α, MIP1β8, and IP-10, in the tumour tissue after chemotherapy treatment. This evidence concerns the gene CCL3 and neoplasm.